Last reviewed · How we verify
NCT04841941
A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use
NA trial testing G4 Multifocal soft contact lens with a 54% water content for presbyopia in Presbyopia in 25 participants. Completed in 16 February 2021.
16 February 2021
Quick facts
| Lead sponsor | Hanita Lenses |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 25 |
| Start date | 17 July 2018 |
| Primary completion | 16 February 2021 |
| Estimated completion | 16 February 2021 |
| Sites | 2 locations across Israel |
Drugs / interventions tested
- G4 Multifocal soft contact lens with a 54% water content for presbyopia
Conditions studied
- Presbyopia — all drugs for Presbyopia →
Sponsor
Hanita Lenses
Who can join
18 and older, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The G4 Multi multifocal contact lens is a soft contact lens intended to correct far, intermediate, and near vision for individuals with presbyopia. The lens covers the cornea and part of the sclera. The lenses can be used for daily wear for up to 1 year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04841941
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Hanita Lenses trials
Trials by the same sponsor.
- NCT06084169 — Investigation for Assessing the Visual Performance of Hanita Lenses Intensity SL IOL in Comparison to Alcon Panoptix IOL · NA · unknown
- NCT06220331 — Data Collection After Intensity IOL Implantations · completed
- NCT06083025 — Influence of CleaRing Open-capsule Device on Refractive Predictability in Cataract Patients (Part 2) · NA · unknown
- NCT06075459 — Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses "Intensity SL" Intraocular Lens · completed
- NCT05504343 — Assessing The Visual Performance Of Hanita Lenses "Intensity SL" Intraocular Lens · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04841941 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hanita Lenses
- Last refreshed: 12 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04841941.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing